Literature DB >> 27633296

Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: An in silico approach.

Hamza Dar1, Tahreem Zaheer1, Muhammad Talha Rehman1, Amjad Ali1, Aneela Javed2, Gohar Ayub Khan1, Mustafeez Mujtaba Babar3, Yasir Waheed4.   

Abstract

OBJECTIVE: To predict immunogenic promiscuous T cell epitopes from the polyprotein of the Zika virus using a range of bioinformatics tools. To date, no epitope data are available for the Zika virus in the IEDB database.
METHODS: We retrieved nearly 54 full length polyprotein sequences of the Zika virus from the NCBI database belonging to different outbreaks. A consensus sequence was then used to predict the promiscuous T cell epitopes that bind MHC 1 and MHC II alleles using PorPred1 and ProPred immunoinformatic algorithms respectively. The antigenicity predicted score was also calculated for each predicted epitope using the VaxiJen 2.0 tool.
RESULTS: By using ProPred1, 23 antigenic epitopes for HLA class I and 48 antigenic epitopes for HLA class II were predicted from the consensus polyprotein sequence of Zika virus. The greatest number of MHC class I binding epitopes were projected within the NS5 (21%), followed by Envelope (17%). For MHC class II, greatest number of predicted epitopes were in NS5 (19%) followed by the Envelope, NS1 and NS2 (17% each). A variety of epitopes with good binding affinity, promiscuity and antigenicity were predicted for both the HLA classes.
CONCLUSION: The predicted conserved promiscuous T-cell epitopes examined in this study were reported for the first time and will contribute to the imminent design of Zika virus vaccine candidates, which will be able to induce a broad range of immune responses in a heterogeneous HLA population. However, our results can be verified and employed in future efficacious vaccine formulations only after successful experimental studies.
Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigenicity; B-cell epitopes; T-cell epitopes; Vaccine; Zika virus

Year:  2016        PMID: 27633296     DOI: 10.1016/j.apjtm.2016.07.004

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  14 in total

1.  Rapid microsphere-assisted peptide screening (MAPS) of promiscuous MHCII-binding peptides in Zika virus envelope protein.

Authors:  Mason R Smith; Luke F Bugada; Fei Wen
Journal:  AIChE J       Date:  2019-06-11       Impact factor: 3.993

2.  Rapid Identification of MHCII-Binding Peptides Through Microsphere-Assisted Peptide Screening (MAPS).

Authors:  Luke F Bugada; Mason R Smith; Fei Wen
Journal:  Methods Mol Biol       Date:  2022

3.  In silico designed Staphylococcus aureus B-cell multi-epitope vaccine did not elicit antibodies against target antigens suggesting multi-domain approach.

Authors:  Nimat Ullah; Farha Anwer; Zaara Ishaq; Abubakar Siddique; Majid Ali Shah; Moazur Rahman; Abdur Rahman; Xinrui Mao; TingTing Jiang; Bok Luel Lee; Taeok Bae; Amjad Ali
Journal:  J Immunol Methods       Date:  2022-03-25       Impact factor: 2.287

4.  Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins.

Authors:  Muhammad Usman Mirza; Shazia Rafique; Amjad Ali; Mobeen Munir; Nazia Ikram; Abdul Manan; Outi M H Salo-Ahen; Muhammad Idrees
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

5.  Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests.

Authors:  Aaron L Oom; Davey Smith; Kevan Akrami
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

6.  Identification of relevant regions on structural and nonstructural proteins of Zika virus for vaccine and diagnostic test development: an in silico approach.

Authors:  E A Salvador; G A Pires de Souza; L C Cotta Malaquias; T Wang; L F Leomil Coelho
Journal:  New Microbes New Infect       Date:  2019-01-31

Review 7.  Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.

Authors:  Claude Roth; Félix G Delgado; Etienne Simon-Lorière; Anavaj Sakuntabhai
Journal:  Int J Environ Res Public Health       Date:  2018-02-23       Impact factor: 3.390

8.  Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.

Authors:  Anam Naz; Fatima Shahid; Tariq Tahir Butt; Faryal Mehwish Awan; Amjad Ali; Arif Malik
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

9.  Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.

Authors:  Félix G Delgado; Karina I Torres; Jaime E Castellanos; Consuelo Romero-Sánchez; Etienne Simon-Lorière; Anavaj Sakuntabhai; Claude Roth
Journal:  Viruses       Date:  2018-09-07       Impact factor: 5.048

10.  New Computational Approach for Peptide Vaccine Design Against SARS-COV-2.

Authors:  Subhamoy Biswas; Smarajit Manna; Ashesh Nandy; Subhash C Basak
Journal:  Int J Pept Res Ther       Date:  2021-07-10       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.